SLC2A1 and melanoma: Decreasing SOX2 expression in melanoma cells was associated with a shift towards glycolysis, with increased lactate production and higher expression of SLC2A1/3 (also known as GLUT1/3), and hexokinase 2, which help import glucose and catalyze glycolysis in cells [20].